BSE filing, NSE: UNICHEMLAB. Summary written from the filing by ALFA Finder's alert engine.
Unichem Laboratories Ltd: key numbers
- Share price
- ₹483.75
- Market cap
- ₹3,406 Cr
- Revenue (annual)
- ₹2,202 Cr
- Net profit (annual)
- ₹252.8 Cr
- P/E (TTM)
- 11.2×Sector 45.9×
- Promoter holding
- 70.22%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unichem Laboratories Ltd
All →Unichem Laboratories Board Meeting Date
Unichem Laboratories intimated that its Board will meet on November 4, 2026 to consider Q2 and H1 FY27 unaudited results. The meeting has not yet occurred.
Unichem Laboratories Other Announcement
Unichem Laboratories Limited submitted the quarterly compliance certificate under SEBI Regulation 74(5) as provided by its Registrar and Share Transfer Agent.
Unichem Laboratories Business Update
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories Legal & Regulatory
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
- Value
- ₹93.66 Cr
Unichem Laboratories Employee Stock Options
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories Price Movement Clarification
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.
Other adverse business impact announcements
All →Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.
IIFL Capital Services Adverse Business Impact
IIFL Capital Services' subsidiary surrendered its SEBI Investment Adviser registration, effective October 28, 2026. The company states there is no material monetary impact and no penalty.